Stay updated on VAX-24 Safety in Older Adults Clinical Trial
Sign up to get notified when there's something new on the VAX-24 Safety in Older Adults Clinical Trial page.

Latest updates to the VAX-24 Safety in Older Adults Clinical Trial page
- ChecktodayChange DetectedThe footer revision identifier was updated from v3.8.0 to v3.8.1.SummaryDifference0.0%

- Check7 days agoChange DetectedThe clinical trial record for the VAX-24 vaccine study in adults aged 65 and older is displayed, including study design, eligibility criteria, locations, outcome measures, results, and study documents.SummaryDifference59%

- Check14 days agoChange DetectedThe footer revision label was updated from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check28 days agoChange DetectedAn NIH-wide announcement about terminology changes appears above the ClinicalTrials.gov page, and the footer revision advances from v3.7.1 to v3.7.2. The study page itself continues to show a 403 error.SummaryDifference1%

- Check42 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1; the study page continues to display a 403 Forbidden message.SummaryDifference0.2%

- Check56 days agoChange DetectedThe study page now shows a 403 Forbidden error, replacing the expected content. A Home link is displayed for navigation.SummaryDifference18%

Stay in the know with updates to VAX-24 Safety in Older Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VAX-24 Safety in Older Adults Clinical Trial page.